Deepcell
PrivateLast Round
Series B
Mar 17, 2022
Total Funding Raised
$98M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Deepcell is a biotechnology company that provides an AI-powered single cell classification and isolation technology for clinical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Medical AI, Computer Vision
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deepcell Comparables
Compare Deepcell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ThinkCyte | 88% | |
| NanoCellect Biomedical | 81% | |
| LevitasBio | 79% |
Deepcell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 17, 2022 | ||||
| Series A | Dec 10, 2020 | ||||
| Seed | Dec 27, 2017 |
Key People
Founding team and executive leadership
Deepcell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Series B, Seed |
| Horizons Ventures | Series B |
| Stanford University | Series A |
| Catalio Capital Management | Seed |
| Koch Disruptive Technologies | Series B |
| Bow Capital | Series B, Series A |
| Casdin Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 113% MoM, from 2.4K to 5K.
- Jul 20, 2026
Open roles increased from 0 to 30, representing 91% of headcount.
Recent news
Latest coverage and updates
- receives_financingSep 10, 2026
Deepcell, Inc. received financing of $14.9M in venture funding on Aug 1st '26.
- is_developingAug 20, 2026
Deepcell, Inc. is developing custom foundation model for Chinese hamster ovary cell morphology on Aug 20th '26.
- partners_withAug 20, 2026
Deepcell, Inc. partnered with Gilead Sciences, Inc. on Aug 20th '26.
Deepcell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Deepcell's valuation, stock price, and market status.
Is Deepcell a public or private company?
Deepcell is a private company.
What is the current stock price of Deepcell?
Deepcell is a private company with no public stock price. No recent secondary market data is available.
How much is Deepcell worth (valuation)?
Valuation information for Deepcell is not publicly available.
Can I buy Deepcell stock?
Deepcell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Deepcell's last funding round?
Deepcell's most recent funding round was Series B on March 17, 2022.
Who are the main investors in Deepcell?
Key investors in Deepcell include Andreessen Horowitz, Koch Disruptive Technologies, Bow Capital.
Will Deepcell IPO soon?
No public IPO plans have been announced for Deepcell.
How can I track Deepcell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Deepcell's secondary market activity and sign up for updates.